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1 INTRODUCTION 
1.1 Nitric oxide 
For a long time nitric oxide (NO) has been known as a rather toxic gas that reacts 
with oxygen to yield the even more harmful NO2 radical (Kirsch, M., et al. 2002). 
On the other hand, nitric oxide was identified as an important messenger molecule 
in living organisms (Furchgott, R. F. and Zawadzki, J. V. 1980), that was at first 
called endothelium derived relaxing factor (ERDF). The ERDF was discovered in 
1980 (Furchgott, R. F. and Zawadzki, J. V. 1980) and in human beings in 1987 
(Palmer, R. M. J., et al. 1987). Later on the ERDF was identified as nitric oxide 
because of its parallelism to nitrates, i.e. glyceroltrinitrate. 
 
Three nitric oxide-generating isoenzymes (nitric oxide synthases NOS I-III) are 
known in human beings (Gabriel, C., et al. 1997, Gryglewski, R. G., et al. 2002). 
We differentiate between neuronal NOS, nNOS=NOS I, inducible NOS, 
iNOS=NOS II and the endothelium NOS, eNOS=NOS III (Gabriel, C., et al. 1997, 
Gryglewski, R. G., et al. 2002). In all cases the amino acid L-arginine is - in the 
presence of the cofactor tetrahydrobiopterin, the coenzyme NADPH, and oxygen - 
oxidized to citrulline thereby generating NO (Kwon, N. S., et al. 1989). Whereas 
the iNOS is induced in inflammation and shock (Gabriel, C., et al. 1997, Palmer, R. 
M. J., et al. 1987) the endothelial NOS is mainly activated by acetylcholine. In all 
cases of activation, the released nitric oxide activates the heme-containing enzyme 
soluble guanylyl cyclase (sGC) (Ahlner, J., et al. 1991, Feelisch, M. and Noack, E. 
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1989, Schönafinger, K. 1999, Schrammel, A., et al. 1998) thus increasing the 
second messenger cGMP (cyclic guanosine monophosphate) (Gabriel, C., et al. 
1997, Kankaanranta, H., et al. 1997). 
Since it is known that NO is able to diffuse across cell membranes (Gabriel, C., et 
al. 1997) there is no general need that exogenous NO must be formed 
intracellularly.  
 
A variety of physiological effects of NO are evident, e.g. vasodilatation by smooth 
muscle relaxation, regulation of neurotransmission, and immune defence 
(Kankaanranta, H., et al. 1997, Lohse, M. J., et al. 1998). Additionally, there are 
some reports, that NO directly inhibits the respiratory chain, most likely by 
inhibition of the cytochrome oxidase (Brown, G. C. 1999, Granger, D. L. and 
Lehninger, A. L. 1982, Schweizer, M. and Richter, C. 1994). 
At low concentrations, NO produced by nNOS and eNOS, located in the 
endothelium and the brain, has beneficial effects like vasodilatation and anti-
aggregation of platelets (Karow, T. and Lang-Roth, R. 2002, Palmer, R. M. J., et al. 
1987). In inflammation or shock, the iNOS produces orders of magnitude more 
nitric oxide than the other nitric oxide synthases, and this may cause dangerous 
hypotension and cell damage (Karow, T. and Lang-Roth, R. 2002, Palmer, R. M. 
J., et al. 1987). Some authors reported about some protective effects of 
endogenous NO from nNOS, mediated by NMDA receptor modulation (Manzoni, 
O., et al. 1992) and it is believed that NO exert an antioxidative effect via 
scavenging of highly harmful radicals like the HO. radical (Dendorfer, A. 1996). 
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Healthy endothelial cells are able to release nitric oxide, that causes on the one 
hand relaxation of smooth muscle cells of vessels, mainly of veins and coronary 
arteries, and on the other hand anti-aggregation of platelets. In either 
arteriosclerosis or stenosis of a vessel, the body is not able to compensate the 
deficit of endogenous nitric oxide, and such diseases go together with a 
dysfunction of endothelial NO release (Dendorfer, A. 1996, Gryglewski, R. G., et al. 
2002). Thus the application of an exogenous nitric oxide releasing drug is then the 
main therapeutic goal in order to compensate for the deficit of endogenous NO. 
Therefore, a variety of nitric oxide releasing drugs were developed during the past 
years for treatment of angina pectoris, ischaemic heart disease, chronic heart 
failure, heart insufficiency, atherosclerotic, and hypertensive diseases (Dendorfer, 
A. 1996, Feelisch, M. 1998, Wilson, I. D., et al. 1987).  
The main group of therapeutic NO donors are organic nitrates, such as 
glyceroltrinitrate (GTN), isosorbitdinitrate (ISDN) and pentaerithrityltetranitrate 
(PETN), which generate mainly enzyme-dependently nitric oxide (Feelisch, M. 
1998). Another group of NO donors, including molsidomine, only generate NO in a 
non-enzymatic way.  
1.2 The sydnonimine Molsidomine 
Molsidomine, commonly named as Corvaton®, is a pharmacon rapidly absorbed 
by the gastro-intestinal tract (Singlas, E. and Martre, H. 1983). Then it is 
enzymatically hydrolized by hepatic esterases (Schrammel, A., et al. 1998) to yield 
CO2, ethanol, and SIN-1 (Schrammel, A., et al. 1998). Figure 1 shows the 
decomposition of molsidomine releasing NO and O2.–. Consequently, Molsidomine 
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is a so-called prodrug (Feelisch, M. and Noack, E. 1989), decomposing into the 
active metabolite SIN-1.  
 
 
 
 
Figure 1: Mechanism of NO and O2.– release from Molsidomine in in vitro systems: 
Molsidomine enzymatically decomposes to SIN-1 thus releasing CO2 and ethanol. At a pH>5 it 
spontaneously decomposes to SIN-1A. In the presence of O2 SIN-1.+ is yielded under the release of 
O2.–. Finally, splitting yielded NO, H+ and the pharmacologically inactive form SIN-1C.  
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1.3 SIN-1 
SIN-1 is the abbreviation for 3-Morpholinosydnonimine. In 1970 in Sydney it was 
first synthesized (Matusa, K. and Imashiro, Y. 1970) and such chemical functions 
are called sydnonimines. The half-time of this pharmacological entity lies between 
60 and 90 minutes.  
SIN-1 decomposes spontaneously to the substance SIN-1A (Fig.1) (Schönafinger, 
K. 1999). The pharmacological efficacy of SIN-1 is believed to be mediated by this 
substance, SIN-1A, which in the presence of O2 spontaneously fragmentizes to 
yield SIN-1C, nitric oxide, and superoxide, respectively (Schönafinger, K. 1999) 
(Fig.1). 
In some literature the decay of SIN-1 is explained via the intermediate SIN-1.+, a 
radical cation, and O2.– which are directly produced from SIN-1A (Chun-Qi, L. 
2002). The conversion from SIN-1A to SIN-1.+ and SIN-1C, respectively, proceeds 
spontaneously and cannot be inhibited nor counteracted (Ashai, Y., et al. 1971, 
Wilson, I. D., et al. 1987). SIN-1C is known as the inactive endproduct of this 
reaction. 
1.4 SIN-1C 
SIN-1C will be oxidized in the liver to three components called metabolite E (N-
Cyanomethylamino-N-(2`-hydroxyethyl)-glycine), metabolite E1 (N-
cyanomethylamino-2-amino-ethoxy)-acetic acid) (Wilson, I. D., et al. 1986) and 
small amounts of the metabolite I (N-cyanomethyleneamino-diethanolamine). 
Further metabolism can take place in generating SCN–, probably from 
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intermediarly cyanide ion which is formed from the nitrile-containing metabolites of 
molsidomine. 
1.5 Influence of pH and oxygen on decomposition of SIN-1 
Under strictly anaerobic conditions SIN-1A is stable at pH 7.4 in cell-free 
experimental systems, but other electron acceptors than oxygen are expected to 
stimulate the decay of SIN-1A. Oxygen consumption may become important when 
sydnonimines are applied to biological systems. Besides, superoxide and protons 
(H+) are generated during the decay of SIN-1, which may lead to a considerable 
decrease in pH in unbuffered aqueous solutions (Schönafinger, K. 1999). There is 
a correlation of oxygen consumption and NO formation in buffered SIN-1 solutions 
(Feelisch, M., et al. 1989). It is known that increasing oxygen concentrations 
enhances nitric oxide generation from SIN-1. 
1.6 Releasing compounds of SIN-1: 
Superoxide and nitric oxide generate peroxynitrite 
As mentioned before, SIN-1 spontaneously decomposes to SIN-1C, superoxide 
and nitric oxide. The latter two radicals - superoxide and nitric oxide - recombine in 
a diffusion-controlled reaction to the harmful compound peroxynitrite ONOO– (k = 
3.9-16 x 109 M-1 s-1 (Kissner, R. and Koppenol, W. H. 2002, Ross, A. B., et al. 
1998)). Figure 2 shows 3 hepatocytes as representative cells in order to 
demonstrate the known chemical reactions (black arrow) and hypothetical cell 
membrane permeation pathway (green arrow) of SIN-1, SIN-1C and NO. 
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Figure 2: Intracellular pathway of Molsidomine in hepatocytes: 3 hepatocytes as 
representative cells demonstrate the known chemical reaction of SIN-1 to SIN-1C, O2.– and NO. 
These reactions are shown with black arrow. Hypothetical reactions are marked with green arrows. 
Molsidomine enters the hepatocytes and decomposes to SIN-1. SIN-1 might pass cell membranes 
or decompose inside to its decomposition product SIN-1C, thereby releasing nitric oxide and 
superoxide. The latter compounds may react to peroxynitrite. Also SIN-1C and nitric oxide may be 
able to pass the cell membrane, indicated by the green arrow.  
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1.7 Superoxide  
As the superoxide dismutase activity is high in most cells (Huie, R. E. and 
Padmaja, S. 1993, Tyler, D. D. 1992) and because electron acceptors other than 
oxygen can additionally stimulate the decay of SIN-1A (Werringloer, J., et al. 
1990), one can expect that nitric oxide rather than peroxynitrite is generated in vivo 
and that it is intracellularly generated from SIN-1, provided SIN-1 enters the cells. 
To the best of our knowledge, however, it is at present not known whether SIN-1 
can penetrate cells. In experimental cell culture studies this highly important 
possibility is generally ignored because SIN-1 is frequently used as an extracellular 
peroxynitrite source, see e.g. (Bouton, C., et al. 1997, Chun-Qi, L. 2002, Doulias, 
P. T., et al. 2001, Garcia-Nogales, P., et al. 2003, Kaji, T., et al. 2002).  
1.8 Aims of the study 
Since SIN-1 is often used in experimental systems for the in situ generation of 
stoichiometric amounts of peroxynitrite (ONOO–) (Feelisch, M., et al. 1989, 
Gryglewski, R. G., et al. 2002, Huie, R. E. and Padmaja, S. 1993) and regarding 
the fact that SIN-1 initially yields nitric oxide and superoxide it is actually unclear 
whether SIN-1 and its degradation product SIN-1C are capable to pass cell 
membranes thus generating nitric oxide and peroxynitrite intracellulary or only 
peroxynitrite extracellularly. In the present investigation L-929 mouse fibroblasts 
were selected as a typical tissue cell. Due to the fact that peroxynitrite and nitric 
oxide diametrically affected the cellular NAD(P)H-level, the following questions 
were clarified:  
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1.) Can SIN-1 and SIN-1C penetrate cell membranes? 
2.) Does the cell type support the release of NO from SIN-1? 
3.) Are reactive nitrogen-oxide species intracellularly formed? 
4.) Is the content of NAD(P)H in the cytosol, mitochondrium and nuclei affected by 
SIN-1? 
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2 MATERIALS AND CELL CULTURE 
2.1 Chemicals 
Chemical      Company 
 
Penicillin      Gibco (Eggenstein, Germany) 
Streptomycin     Gibco (Eggenstein, Germany) 
Potassium cyanide KCN    Behring (Mannheim, Germany) 
Bovine serum albumin BSA   Behring (Mannheim, Germany) 
Fetal bovine serum     Sigma (Steinheim, Germany) 
Superoxide Dismutase SOD   Roche (Basel, Switzerland) 
Minimum essential medium Eagle MEM  Sigma (Steinheim, Germany) 
Metaphosphoric acid (8%)    Sigma (Steinheim, Germany) 
Tri-Glycine      Sigma (Steinheim, Germany) 
L-Glutamine      Sigma (Steinheim, Germany) 
Pluronic      Sigma (Steinheim, Germany) 
Probenecid      Sigma (Steinheim, Germany) 
Spermine NONOate    Situs (Düsseldorf, Germany) 
Dimethyl Sulfoxide DMSO    Merck (Darmstadt, Germany) 
Fluorescent dyes: 
Fluorescent Nitric Oxide Cheletropic Trap Prof. Dr. Dr. R. Sustmann  
F-NOCT-1AM and FNOCT-1  Department of Organic Chemistry, 
Essen University 
Diaminofluorescein-diacetate DAF-2 DA Alexis Biochemicals,  
(Grünberg, Germany) 
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SIN-1 and SIN-1C     Drs. K. Schönafinger and J. Pünter 
(Aventis, Frankfurt/ Main, Germany) 
Gases (5%CO2/21%O2/74%N2)   Messer-Griessheim  
(Oberhausen, Germany) 
Cell culture plastic flasks 175cm2   Falcon (Heidelberg, Germany) 
Cell culture plastic flasks 75 cm2   Falcon (Heidelberg, Germany) 
Cell culture six-well-plastic flasks   Falcon (Heidelberg, Germany) 
Cell culture plastic plates    Falcon (Heidelberg, Germany) 
Glass coverslips     Assistent (Sondheim/ Röhn,  
Germany)  
All chemicals were of the highest purity commercially available. 
2.2 Buffer solutions 
PBS (phosphate buffered saline): pH 7.4 
NaCl 136.0 mM 
KCl 2.7 mM 
Na2HPO4 10.2 mM 
KH2PO4 1.5 mM 
 
MOPS (3-morpholino-propane-sulfone acid) buffer pH 6.3 
NaCl 137.0 mM 
KCl 5.4 mM 
CaCl2 1.0 mM 
MgCl2  0.5 mM 
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KH2PO4 0.4 mM 
MgSO4 0.4 mM 
Na2HPO4 0.3 mM 
Daily added: 
L-Glutamine 2.0 mM 
MOPS (3-morpholino-propane-sulfone acid) 2.5 mM 
 
Buffer A pH 7.4 
NaCl 136.0 mM 
KCl 5.4 mM 
CaCl2 1.3 mM 
MgCl2  0.4 mM 
KH2PO4 0.4 mM 
MgSO4 0.7 mM 
Na2HPO4 0.4 mM 
NaHCO3 23.0 mM 
Pluronic 0.1 % 
Probenecid 1.0 mM 
Daily added: 
Tri-glycine 25.0 mM 
L-Glutamine 2.0 mM 
 
Hanks balanced salt solution (modified): pH 7.4 
NaCl 137.0 mM 
KCl 5.4 mM 
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CaCl2 1.0 mM 
MgCl2 0.5 mM 
KH2PO4 0.4 mM 
MgSO4 0.4 mM 
Na2HPO4 0.3 mM 
Daily added: 
L-Glutamine  2.0 mM 
Tri-glycine  25.0 mM 
2.3 Cell culture of L-929 mouse fibroblasts 
The murine fibroblast-derived cell line L-929 was obtained from the American Type 
Cell Culture Collection (ATTC, NCTC clone 929 of strain L). Cells were cultured in 
minimum essential medium Eagle, MEM, supplemented with 25 mM sodium 
bicarbonate, 10% fetal calf serum, 2 mM L-glutamine, penicillin (50 units/ml) and 
streptomycin (50 µg/ml) in 75 cm2 plastic flasks at 37°C in a humidified 
atmosphere of 5%CO2/21%O2/74%N2. Subcultivation was performed by 
trypsinisation (removing cells from each other and their culture plates using 
trypsine) every 2-3 days (Lomonosova, E., et al. 1998).  
For experiments using capillary zone electrophoresis 5.0 x 106 cells were seeded 
onto 176 cm2 plastic flasks and cultured for 48 h (final density: 2.0 x 107 cells). 
For fluorescence and nitric oxide measurements 1.0 x 105 cells were seeded onto 
6.2 cm2 glass coverslips in 6-well cell culture plates and cultured for 48 hours. 
Experiments with L-929 mouse fibroblasts were started on day 2 after 
subcultivation. 
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For the experiments performed with the nitric oxide electrode, the digital 
fluorescence microscope and the laser scanning microscope, a buffer solution 
(buffer A, pH 7.4, ingredients see above) was prepared.  
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3 METHODS 
3.1 Determination of the uptake of SIN-1 and SIN-1C in L-929 
mouse fibroblasts  
The cellular uptake of SIN-1 and its stable decomposition product SIN-1C, 
respectively, were determined using capillary zone electrophoresis (Beckman 
P/ACE 5000; Beckman, Munich, Germany). SIN-1 100-fold stock solutions were 
prepared with phosphate buffer (50 mM KH2PO4, pH 5.0) at 4°C and kept on ice 
until use (within 30 minutes). 48 h before starting experiments L-929 mouse 
fibroblasts were cultured in MEM on 176 cm2 plastic flasks. On the day of the 
experiment, cells were washed three times with phosphate buffered saline (PBS, 
ingredients see above) and then incubated in a humidified atmosphere 
(5%CO2/21%O2/74%N2) with 2 mM SIN-1 for 5, 60 or 120 min at 37°C in a 
modified Hanks balanced salt solution (ingredients see above) at pH 7.4. 
Afterwards, cells were again washed three times with PBS buffer and an aliquot (1 
ml) of the buffer from each washing step was analysed by capillary zone 
electrophoresis (see figure 3). L-929 cells were then lysed with 150 µl of 8% 
metaphosphoric acid and the lysate was centrifugated at 7500 x g for 5 min at 
room temperature.  
The amounts of SIN-1 and SIN-1C were determined within the supernatant fraction 
(400 µl) of each: a) the incubation buffer, b) the PBS buffer samples after the 
washing steps and c) the cell lysate. The separation conditions for capillary zone 
electrophoresis were as follows: fused silica capillary (50 cm effective length, 75 
µm internal diameter), hydrodynamic injection for 5 s, temperature 23°C, voltage 
20 kV, normal polarity, UV detection at 214 nm, and 100 mM NaHPO4/Na2PO4, 
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(pH 6.3) as electrolyte system; µAMP: ca. 85, outlet: 254 nm (Lomonosova, E., et 
al. 1998). Concentrations of SIN-1 and SIN-1C were calculated from respective 
standards prepared either with PBS or 8% metaphosporic acid. Control 
experiments with L-929 cells in the absence of SIN-1 were performed under the 
same conditions. 
Migration times in capillary zone electrophoresis for SIN-1 (SIN-1C) were 4.6-4.9 
min (7.3-7.7 min) in PBS and 5.8-6.3 min (11.8-13.2 min) in 8% metaphosporic 
acid, respectively. 
3.1.1 Determination of cellular protein content  
The protein content of the biological samples was determined using an assay 
introduced by Bradford (Bradford, M. M. 1976) with bovine serum albumine as 
standard. The reagent solution is 100 mg Coomassie brilliant blue G-250 solution 
in 50 ml 96% ethanol, which is mixed with 100 ml 85% phosphor acid and 850 ml 
water. Afterwards, the mixture was purified by filtration. 3 ml of this Bradford 
reagent was added to 100 µl probe (10-100 µg protein) and after 10 min the optical 
density was read at 595 nm. In case of 1-10 µg protein the microanalysis is 
common using 1 ml Bradford reagent added to 100 µl probe. 
Bovine serum albumine was used as a standard with 1 mg/1 ml H2O, so that 1 
µg/µl protein content could be calculated. First of all, a calibration curve was made, 
afterwards samples were measured. 
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Figure 3: Capillary zone electrophoresis (Beckmann P/ACE 5000; Beckman, Munich, Germany) 
 
Figure 4: Digital fluorescence microscope (Axiovert 135 TV; Zeiss, Oberkochen, Germany) 
 
Figure 5: Amperometric NO sensitive electrode (ISO-NO; World Precision Instruments, Sarasota, 
Florida, USA) 
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3.2 NAD(P)H fluorescence measurement 
3.2.1 Recording of cellular NAD(P)H fluorescence  
Cellular NAD(P)H fluorescence was recorded with a digital fluorescence 
microscope (Axiovert 135 TV; Zeiss, Oberkochen, Germany) see figure 4 equipped 
with the Attofluor imaging system (Atto Instruments, Rockville, MD, USA) as 
described previously (Petrat, F., et al. 2003, Petrat, F., et al. 2003). Measurements 
were performed at 37°C using an excitation filter of λexc. = 365±12.5 nm, and 
monitoring the emission at λem. = 450-490 nm with a bandpass filter. Cellular 
NAD(P)H fluorescence was recorded at 120 s intervals with an excitation period of 
0.3 s and the intensity of the exciting mercury short arc photo optic lamp 
attenuated 40% using gray filters to minimize photochemical effects. Single cell 
fluorescence was determined by manually confining the regions of interest to 
individual cells.  
After establishing NAD(P)H baseline fluorescence (6-10 min in buffer A), SIN-1, 
SIN-1C, or spermine NONOate (2 mM each) were added to the cells and the 
temperature was held at 37°C during the experiment. 
3.2.2 Determination of the subcellular distribution of NAD(P)H  
A laser scanning microscope (LSM 510, Zeiss, Oberkochen, Germany) equipped 
with an UV laser was used (Petrat, F., et al. 2003). The glass coverslips with 
adherent cells were transferred to a modified Pentz chamber and cells were 
washed three times with PBS (37°C). Afterwards, the cells were covered with the 
buffer A and the experiments were performed at room temperature. Subcellular 
NAD(P)H distribution was determined from its subcellular fluorescence at λexc. = 
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365 nm and λem. = 385-470 nm. The objective lens was a 63 x NA 1.40 Plan-
Apochromat. The scanning parameters were as follows: The pinhole was set at 
130 µm, producing confocal optical slices of less than 1.0 µm thickness. Confocal 
images (scanning time: 7.8 s-2.5 min; zoom-factor: 0.7 to 2.5) were collected at 
different intervals and with different parameters. The power of the laser was set at 
1-20% of intensity in order to minimize photochemical damage of the cells and 
bleaching/redistribution of NAD(P)H fluorescence. Some cases of very dark 
images required electronic brightening of the images. Image processing and 
evaluation were performed using the “physiology evaluation” software of the LSM 
510 imaging system (glow scale procedure). 
3.3 Recording of the intracellular generation of reactive 
nitrogen-oxide species using DAF 
The intracellular production of reactive nitrogen-oxide species other than NO (e.g. 
N2O3) was visualized with the scavenger diaminofluorescein DAF-2. 
The substance DAF-2DA is able to pass cell membranes. Intracellular esterases 
convert DAF-2DA into DAF-2 that is not able to pass cell membranes. In the 
presence of reactive nitrogen-oxide species DAF-2 is converted into the 
fluorescence dye DAF-2T. This substance is also membrane impermeable. 
DAF-2 and DAF-2T have an almost identical absorbance and emission maximum 
as well but the quantum yield of fluorescence intensity of the DAF-2T fluorescence 
is more than 180 fold higher than that of DAF-2. Thus the autofluorescence of 
DAF-2 is negligible in regard to the high fluorescence of DAF-2T (Espey, M. G., et 
al. 2001, Räthel, T. R. and Dirsch, V. M. 2003). 
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Figure 6: The fluorescence dye DAF-2: The scavenger diaminofluorescein DAF-2DA is able to 
pass cell membranes. Intracellular esterases convert DAF-2DA into DAF-2 that is not able to pass 
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cell membranes. In presence of reactive nitrogen-oxide species DAF-2 is converted into the 
fluorescence dye DAF-2T. This substance is also membrane impermeable. 
 
Glass coverslips with adherent cells were transferred to a modified Pentz chamber 
and cells were washed three times with warm (37°C) PBS. Cells were kept with 2 
µM DAF-2DA for 1 h in MEM in the dark, as it is sensitive to light. Afterwards the 
cells were washed three times with PBS and covered with buffer A (see above). 
Measurements were performed at 37°C using a digital fluorescence microscope 
(see figure 4) with λexc. = 488±5 nm, and monitoring the emission at λem. = 520±20 
nm using a band-pass filter. When laser microscopy was used, DAF-2 
fluorescence was excited at λexc. = 488 nm and collected through a λem. = 505 nm 
long pass filter. After establishing the intracellular DAF-2 baseline fluorescence (6-
10 min), SIN-1 (2 mM) was added from a concentrated stock solution (see above).  
3.4 Determination of nitric oxide with a NO sensitive electrode 
Extracellular nitric oxide formation was determined using a polarographic 
amperometric NO sensitive electrode (ISO-NO; World Precision Instruments, 
Sarasota, Florida, USA) see figure 5 as described in Ref. (Tsukahara, H., et al. 
1993). During the measurements the temperature was strictly regulated at 37±1°C 
and solutions were continuously stirred during the experiments. The electrode was 
calibrated and the generated NO was quantified according to the instructions of the 
manufacturer using potassium iodide (100 mM) in H2SO4 (0.1 M) as a calibration 
solution to which various amounts of NaNO2 (50 µM) were added. 
The calibration procedure was daily repeated, and plastic vessels were avoided. 
Measurements were performed either in a cell-free system or with L-929 mouse 
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fibroblasts in modified Pentz chambers with buffer A (pH = 7.4) in a 100% 
humidified atmosphere of 5%CO2/21%O2/74%N2. After establishing the baseline 
level of the NO electrode SIN-1 or SIN-1C (2 mM each) were added and the NO 
concentrations recorded.  
3.5 Intracellular NO measurement with the Fluorescent Nitric 
Oxide Cheletropic Trap 
Intracellular generation of NO in L-929 mouse fibroblasts was verified with the 
Fluorescent Nitric Oxide Cheletropic Trap FNOCT-1, which directly and specifically 
traps intracellular NO (Meineke, P., et al. 1999, Meineke, P., et al. 2000). This 
method allows a sensitive and quantitative detection of nitric oxide production in 
biological samples, as it does not cause cell damage. Scavenging of NO converts 
FNOCT-1 into the stable, fluorescent adduct NOCT-NOH. 
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Figure 7: Scavenging of NO converts the fluorescent nitric oxide cheletropic trap FNOCT-1 into the 
stable, fluorescent adduct, FNOCT-NOH. 
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Confluent L-929 mouse fibroblasts were washed three times with PBS (37°C) and 
incubated for 1 h with FNOCT-1AM (50 µM) in buffer A, that additionally contained 
pluronic (0.1%), probenecid (1 mM), glucose (5 mM) and DMSO (0.5%). The 
membrane-permeating acetoxymethylester derivate FNOCT-1AM is intracellularily 
hydrolyzed to the membrane-impermeable compound FNOCT-1 by intracellular 
hydrolases. 
Afterwards intracellular FNOCT-1 fluorescence was recorded using a digital 
fluorescence microscope (see figure 4) at λexc. = 380±10 nm and λem. = 450-490 
nm at 120 s intervals with an excitation period of 0.3 s. Single-cell fluorescence 
was determined by confining the regions of interest manually to individual cells and 
the temperature was held at 37°C during the experiments. 
After establishing the baseline fluorescence (6-10 min), SIN-1 or SIN-1C (2 mM 
each) was added.  
3.6 Cell viability 
The uptake of the dye propidium iodide (5 µg/ml) was routinely determined either 
during or at the end of the experimental procedures in order to detect loss of cell 
viability. The red fluorescence of propidium iodide excited at 543 nm was collected 
through a 560 nm long-pass filter when laser scanning microscopy was used; 
using digital fluorescence microscopy, propidium iodide was detected at λexc  = 
535±17.5 nm and λem. ≥ 590 nm. 
The exclusion of propidium iodide and the fact that intracellular substances like 
DAF-2T and NAD(P)H did not leak out of the cells during the duration of the 
experiments indicated that the plasma membrane remained intact. 
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3.7 Statistics 
All experiments were repeated at least three times. Cellular microfluorographs and 
traces shown in the figures are representative of experiments performed. The 
results are expressed as means ± S.D. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
32
4 RESULTS 
4.1 Evidence that SIN-1 penetrates L-929 cells  
In order to demonstrate that SIN-1 is capable of passing through membranes, 2 
mM of the sydnonimine was added to L-929 cells and experiments performed as 
described above. The amounts of SIN-1 and SIN-1C were determined within the 
supernatant fraction (400 µl) of each: a) the incubation buffer, b) the PBS buffer 
samples after the washing steps and c) the cell lysate. One representative capillary 
zone electrophoresis chromatogram of the last washing solution and one 
representative chromatogram of a cell lysate are shown in figures 8A and 8B. From 
each chromatogram the intracellular content of SIN-1 per mg protein was 
determined. The result is shown in figure 8C. 
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A)      B) 
 
C) 
       
 
Figure 8: L-929 mouse fibroblasts were cultured in MEM on 176 cm2 plastic flasks 48 h before 
starting the experiments. On the day of the experiment, the cells were washed with PBS and 
incubated with SIN-1 (2 mM) in a modified Hanks balanced salt solution at pH 7.4 (37°C). After 
repeating washing the L-929 cells were lysed with 150 µl of 8% metaphosphoric acid. An aliquot of 
the cell lysate was taken and the amount of SIN-1 and SIN-1C analyzed by capillary zone 
electrophoresis. SIN-1 and SIN-1C were identified by spiking with authentic material. 
A) A typical chromatogram of a last washing solution is shown. 
B) Figure 8B shows a typical chromatogram of the L-929 cell lysate. 
C) Figure 8C shows the intracellular amount of SIN-1 per mg protein after an incubation of 5, 20 
and 60 min. Values shown in Figure 8C represent means ± S.D. of three experiments using L-929 
mouse fibroblasts. 
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Already after 5 min of incubation about 5 nmol SIN-1 per mg protein was detected 
in L-929 cells. At prolonged incubation periods, the intracellular content of SIN-1 
decreased moderately. This decrease did not correspond with the known half-life 
of SIN-1, t1/2(SIN-1) = 40 min, in purified buffer solutions (Lomonosova, E., et al. 
1998, Schrammel, A., et al. 1998). However, such a decreased decay has been 
already reported by Meinertz et al. (Meinertz, T., et al. 1985). From a SIN-1 content 
of about 5 nmol/mg protein the concentration was estimated with the assumption 
that the volume of a single fibroblast is 3.5 pl (Dall´Asta, V., et al. 1994, Dall´Asta, 
V., et al. 1994, Mastrocola, T., et al. 1993) yielding an intracellular concentration of 
SIN-1 of 0.9±0.3 mM, i.e. approximately half the concentration in the supernatant 
(2 mM) respectively.  
Intracellular SIN-1C could only be found at marginal contents (about 55, 110, and 
85 pmol SIN-1C per mg protein after 5, 60, and 120 min). 
Hence, these data clearly demonstrated that SIN-1 but not SIN-1C rapidly 
penetrates L-929 cells. 
4.2 Evidence for an intracellular production of reactive nitrogen-
oxide species from SIN-1 in L929 cells 
Since diffusion of SIN-1 into L-929 cells is quite rapid, we tried to scavenge 
possible intracellularly produced reactive nitrogen-oxide species with the 
scavenger DAF-2DA (2 µM) as a fluorescent indicator. DAF-2 reacts with such 
reactive intermediates to yield the fluorescent dye DAF-2T (Espey, M. G., et al. 
2001). After addition of 2 mM SIN-1 to L-929 cells, a strong, continuous increase in 
the fluorescence of DAF-2T could be monitored by digital fluorescence microscopy 
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(λexc. = 488±10 nm; λem. = 520±20 nm) during the first 15 min. Figure 9 shows the 
curve of this registration.  
 
 
 
Figure 9: Detection of intracellular reactive nitrogen-oxide species generated by SIN-1 using 
digital fluorescence microscopy 
The generation of reactive nitrogen-oxide species in cultured L-929 cells was monitored by digital 
fluorescence microscopy (λexc. = 488±10 nm; λem. = 520±20 nm) utilizing 4.5-diaminofluorescein 
diacetate DAF-2 (2 µM) as a fluorescence indicator. Upon reaction of non-fluorescent DAF-2 with 
intracellular reactive nitrogen species the fluorescent product DAF-2T is intracellularly generated. L-
929 cells were cultured on glass coverslips, washed three times with PBS and incubated for 1 h 
with the membrane–permeable compound DAF-2DA in MEM. Afterwards, cells were washed again 
three times with PBS and then covered with buffer A, pH 7.4 (37°C). After establishing the baseline 
fluorescence, SIN-1 or SIN-1C (2 mM each) was added. Values shown represent means ± S.D of 
three experiments using L-929 mouse fibroblasts from different subcultures. The arrow indicates 
the addition of either SIN-1 or of SIN-1C. 
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In control experiments performed with the pharmacologically inactive compound 
SIN-1C (2 mM), DAF-2T fluorescence did not increase, as also shown in figure 9. 
Data taken with the laser scanning microscope clearly demonstrate an increase of 
fluorescence intensity (figure 10). The stable level of fluorescence intensity is 
shown from photo 1-4. At 30 minutes SIN-1 was added and the increase of 
fluorescence intensity is visible. 
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Photo 1   Photo 2   Photo 3 
 
Photo 4   Photo 5   Photo 6 
 
Photo 7   Photo 8 
Figure 10: Detection of intracellular reactive nitrogen-oxide species generated by SIN-1 
using laser scanning microscopy. The generation of reactive nitrogen-oxide species in cultured 
L-929 cells was visualized by laser scanning microscopy (λexc. = 488±10 nm; λem. = 520±20 nm) 
utilizing 4.5-diaminofluorescein diacetate DAF-2 (2 µM) as a fluorescence indicator. Upon reaction 
of non-fluorescent DAF-2 with intracellular reactive nitrogen species the fluorescent product DAF-
2T is intracellularly generated. L-929 cells were cultured on glass coverslips, washed three times 
with PBS and incubated for 1 h with the membrane–permeable compound DAF-2DA in MEM. 
Afterwards, cells were washed again three times with PBS and then covered with buffer A, pH 7.4 
(37°C). After establishing the baseline fluorescence shown in photo 1-4, SIN-1 (2 mM) was added 
at time point 30 min. The following pictures show the increase of fluorescence intensity. 
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These experiments indicated that RNOS like N2O3 or NO2 are intracellularly 
produced from SIN-1 in L-929 cells. 
4.3 Evidence for the generation of freely diffusing NO from 
intracellularly operating SIN-1 in L-929 cells 
4.3.1 Nitric oxide sensitive electrode 
Because the DAF-2 nitrosating intermediates should have been derived from 
initially released NO at pH 7.0-7.5, we monitored the production of nitric oxide from 
SIN-1 using a polarographic amperometric NO-sensitive electrode. NO was 
quantified on basis of daily performed calibrations as explained above. 
4.3.1.1 Cell free system 
In the absence of L-929 cells, SIN-1-dependent formation of freely diffusing nitric 
oxide was not detectable in regard to the detection limit of 1 nM. Figure 11 shows 
the comparison with nitric oxide release in cell free and cellular system. Obviously, 
the release of nitric oxide was undetectable in a cell free system.  
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Figure 11: Electrochemically monitored formation of nitric oxides from SIN-1  
Formation of nitric oxide was detected by using a polarographic amperometric NO sensitive 
electrode. NO was quantified on basis of daily performed calibrations. Formation of NO from SIN-1 
(2 mM) was measured at 37°C within chemical - cell free system - and in the supernatant (buffer A) 
of L-929 cells. Glass coverslips with adherent cells were transferred to a modified Pentz chamber 
and cells washed three times with 2 ml warm (37°C) PBS buffer before buffer A was added. Values 
shown in Figure 11 represent means ± S.D of three experiments using L-929 mouse fibroblasts 
from different subcultures. 
 
4.3.1.2 Cell system 
Formation of NO from SIN-1 (2 mM) was additionally measured at 37°C within the 
supernatant (buffer A) of L-929 cells. The development of nitric oxide release was 
recorded and the results are shown in Figure 12. In the presence of L-929 cells (4 
x 105 cells/ cm2), however, formation of NO could be monitored with an initial rate 
of 10.2±5.9 nM/ min. A “plateau” concentration of ca. 160 nM NO was established 
after 45 min (Fig. 12). These observations are at variance with data of Haddad et 
al. (Haddad, I. Y., et al. 1996) who found that alveolar type II cells did not release 
Nitric oxide release after addition of 2mM SIN-1 
in a cell free system and in L-929 cells. 
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any freely diffusing nitric oxide after incubation with SIN-1. Such a discrepancy 
may well be due to the inherent metabolism of the cells. 
 
Figure 12: Electrochemically monitored formation of nitric oxides from SIN-1  
Formation of nitric oxide was detected by using a polarographic amperometric NO sensitive 
electrode. NO was quantified on basis of daily performed calibrations. Formation of NO from SIN-1 
(2 mM) was measured at 37°C within chemical - cell free-system - and in the supernatant (buffer A) 
of L-929 cells. Glass coverslips with adherent cells were transferred to a modified Pentz chamber 
and cells washed three times with 2 ml warm (37°C) PBS buffer before buffer A was added.The 
trace shown indicates the SIN-1 dependent formation of nitric oxide in the supernatant of the L-929 
cell cultures showing an initial rate of 10.2 ± 5.9 nM/min and a plateau concentration of ca. 160 nM 
NO. Values shown represent means ± S.D. of three experiments using L-929 mouse fibroblasts 
from different subcultures.  
4.3.2 NO-scavenger F-NOCT 
To underline and verify the experiments performed with the NO-electrode, 
formation of nitric oxide was intracellularly measured by using the NO scavenger 
FNOCT-1. This compound is highly specific for NO (Meineke, P., et al. 1999, 
Meineke, P., et al. 2000), in contrast to DAF-2, which reacts with reactive nitrogen 
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species but did not scavenge NO (Espey, M. G., et al. 2001). Scavenging of NO 
converts FNOCT-1 into the stable, fluorescent adduct, FNOCT-NOH. On addition 
of 2 mM SIN-1 to L-929 cells preloaded with FNOCT-1AM, the intracellular 
fluorescence of FNOCT-NOH could be detected, the intensity increasing linearily 
with time, thus confirming the trapping of freely diffusing NO as shown in Figure 
13. 
 
Figure 13: SIN-1-dependent formation of NO in L-929 cells as determined with the FNOCT-1 
method 
Cells were cultured on glass coverslips, transferred to a modified Pentz chamber, then washed 
three times with PBS buffer and then incubated with FNOCT-1AM (50 µM) for 1 h in MEM (37°C). 
Afterwards, cells were washed again with PBS buffer and covered with buffer A (37°C). The 
intracellular fluorescence of FNOCT-1 (λexc. = 380 ± 10 nm, λem. = 450-490 nm) was recorded at 
120 s intervals with an excitation time of 0.3 s using digital fluorescence microscopy. After 
establishing the baseline fluorescence, SIN-1 or SIN-1C (2 mM each) was added (arrow). Data are 
representative for at least 5 experiments using L-929 mouse fibroblasts from different subcultures.  
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On the other hand, the background fluorescence level of FNOCT-1AM loaded cells 
was hardly affected by SIN-1C (2 mM). Control experiments performed with SIN-1 
(0.025-1 mM) and FNOCT-1 (50 µM) in the absence of L-929 cells validated the 
expectation that the reaction of NO with FNOCT-1 (k(•NO + FNOCT-1) = 170±10 
M-1 s-1 (Meineke, P., et al. 1999, Meineke, P., et al. 2000) cannot compete with the 
fast reaction of nitric oxide with O2•– (k(•NO + O2•–) = ~ 5 x 109 M-1 s-1 (Kissner, R. 
and Koppenol, W. H. 2002, Ross, A. B., et al. 1998) to form peroxynitrite because 
of the missing FNOCT-NOH fluorescence in these experiments (data not shown).  
Notably, the FNOCT-1/FNOCT-NOH fluorescence intensity was found to be orders 
of magnitude higher than the cellular NAD(P)H fluorescence intensity (data not 
shown), which therefore did not contribute significantly to the changes in the 
observed fluorescence intensity. Thus, the L-929 cells initiated the release of nitric 
oxide from intracellularily decaying SIN-1.  
4.4 Evidence that the intracellular NAD(P)H level is influenced 
by both NO and RNOS in L-929 cells 
Nitric oxide is known to induce an increase in the intracellular, especially the 
intramitochondrial concentration of NAD(P)H by blocking the mitochondrial electron 
transport chain due to reaction with both the heme a3 and copper CuB group of 
cytochrome oxidase (Cooper, C. E. 2002, Horie, Y., et al. 1997). Contrary to NO, 
higher reactive nitrogen-oxide species (RNOS) like NO2 and N2O3 are expected to 
diminish the intracellular level of NAD(P)H via two pathways, i.e. indirectly due to 
an enhanced oxidation of glutathione (Heales, S. J. R. and Bolanos, J. P. 2002, 
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Radi, R., et al. 1991, Sies, H., et al. 1997, Tu, B., et al. 1995) and its regeneration 
by the glutathione reductase/NADPH pathway (Kirsch, M. and de Groot, H. 2001) 
and directly via attack by CO3.- and NO2 radicals (Kirsch, M. and de Groot, H. 
1999) produced from peroxynitrite in the presence of CO2. In order to answer the 
question whether intracellular SIN-1 primarily affects L-929 cells via NO induced 
inhibition of the respiratory chain (indicated by an increase of NAD(P)H) or via 
RNOS (indicated by a decrease of NAD(P)H), the influence of SIN-1 on total 
cellular and subcellular NAD(P)H fluorescence was recorded using digital 
fluorescence microscopy as well as laser scanning microscopy. 
4.4.1 Total intracellular NAD(P)H amount 
As observed by digital fluorescence microscopy, addition of SIN-1 (2 mM) to L-929 
cells resulted in a 40% decrease of the total NAD(P)H fluorescence within 15 min, 
thus indicating a dominating intracellular action of the RNOS as shown in Figure 
14. On the other hand, the NO donor compound Spermine NONOate (2 mM) 
increased the total intracellular NAD(P)H fluorescence by ~12% (Fig. 14), as 
expected for a sole production of NO. In control experiments, addition of KCN (1 
mM), a well-known inhibitor of the respiratory chain, led to a comparable increase 
in the total NAD(P)H fluorescence intensity (data not shown). 
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Figure 14: Effect of SIN-1 and spermine NONOate on the cellular NAD(P)H fluorescence of L-
929 cells 
L-929 mouse fibroblasts were cultured on glass coverslips, transferred to a modified Pentz chamber 
and washed three times with PBS buffer. Afterwards, cells were covered with buffer A (37°C) and 
fluorescence measurements were started. Cellular NAD(P)H fluorescence was recorded at 120 s 
intervals using digital fluorescence microscopy (λexc. =  365±12.5 nm; λem. = 450-490 nm). After 
establishing the baseline fluorescence (5 min), SIN-1 (2 mM) or spermine NONOate (2 mM) were 
added (arrow) to the buffer. The traces shown represent means ± S.D. of 5 experiments using L-
929 mouse fibroblasts from different subcultures.  
4.4.2 Influence on subcellular NAD(P)H level 
In order to verify the effect of SIN-1 on the total cellular NAD(P)H level and to 
elucidate possible changes of NAD(P)H fluorescence within the various subcellular 
compartments, high resolution laser scanning microscopy investigations were 
performed. The effect of SIN-1 (2 mM) on subcellular NAD(P)H fluorescence (λexc. 
= 365 nm; λem. = 385-470 nm) was imaged at the time points indicated using a 
laser scanning microscope equipped with an UV laser. 
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B) 
          
       
Figure 15: Effect of SIN-1 on subcellular NAD(P)H fluorescence of L-929 cells  
L-929 mouse fibroblasts were cultured on glass coverslips, transferred to a modified Pentz chamber 
and washed three times with PBS buffer. Afterwards, L-929 mouse fibroblasts were covered with 
buffer A (37°C) and fluorescence measurements were started. The effect of SIN-1 (2 mM) on 
subcellular NAD(P)H fluorescence (λexc. = 365 nm; λem. = 385-470 nm) was imaged at the time 
points indicated using a laser scanning microscope equipped with an UV laser.  
A) shows images of the whole cells in glow scale. Image processing and evaluation performed with 
the “physiology evaluation” software of the LSM 510 imaging system are called glow scale 
procedure. Bar shown in (A) indicates 10 µm 
B) shows the time evolution of the NAD(P)H fluorescence intensities of the mitochondria, nuclei and 
whole cells as shown in the microfluorographs above. Data shown represent means ± S.D. of 3 
experiments using L-929 mouse fibroblasts from different subcultures.  
baseline 15 min 62 min 47 min
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In Figure 15A changes upon addition of SIN-1 are shown in the subcellular 
distribution of NAD(P)H in L-929 cells, respectively. Traces shown in Figure 15B 
represent the corresponding fluorescence intensity of NAD(P)H as evaluated within 
the mitochondria, nuclei, and cytosol of L-929 fibroblasts.  
In these experiments, addition of 2 mM SIN-1 to L-929 cells led to a small 
decrease (about 20% within 15 min) of the total cellular NAD(P)H fluorescence (Fig 
15A,B). This apparent disagreement to the experiments performed with the digital 
microscopy (Fig. 14) might be explained by the SIN-1-induced morphological 
alterations of the L-929 cells. These alterations may significantly affect the 
detection of cellular NAD(P)H fluorescence when digital fluorescence microscopy 
is used but not when laser scanning microscopy is applied because of optical 
sectioning with this confocal system. In any case, a SIN-1-induced decrease of 
cellular NAD(P)H was obtained with both digital microscopy and laser scanning 
microscopy.  
Evaluation at subcellular levels revealed that SIN-1 decreased the initial cytosolic 
and nuclear NAD(P)H fluorescence intensity by about 60% within the first 15 min. 
On the other hand, mitochondrial NAD(P)H fluorescence was increased by ~ 12% 
(Figs. 15A and 15B), in excellent agreement with the total increase of cellular 
NAD(P)H obtained with the NO donor compound spermine/NO (Fig. 14). These 
observations strongly indicate that SIN-1 diametrically influenced the intracellular 
NAD(P)H concentrations of L-929 cells by both RNOS and nitric oxide. During 
prolonged incubation (ca. 70 min) mitochondrial NAD(P)H fluorescence 
continuously decreased to reach about 70% of its initial level, whereas the 
NAD(P)H fluorescence in the cytosol and nuclei was fully restituted (Fig. 15B). 
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5 DISCUSSION 
There is only very little doubt that in the absence of efficient traps for nitric oxide 
and superoxide SIN-1 almost quantitatively generates peroxynitrite via diffusion-
controlled radical recombination of NO and O2.- in cell-free systems (Kelm, M., et 
al. 1997, Kirsch, M., et al. 1998). In accord, only very low levels of NO (and NO2) 
could be detected by means of cheletropic NO Traps (NOCTs) (Korth, H.-G., et al. 
1994). Because of this, SIN-1 is often used in toxicity studies for the treatment of 
cells with extracellularly generated peroxynitrite (Bouton, C., et al. 1997, Chun-Qi, 
L. 2002, Doulias, P. T., et al. 2001, Garcia-Nogales, P., et al. 2003, Gergel, D., et 
al. 1995, Kaji, T., et al. 2002). In fact, in the presence of alveolar type II cells the 
extracellular SIN-1-dependent formation of peroxynitrite, as demonstrated by 
oxidation of extracellular dihydrorhodamine123, was found to be independent of 
the presence of these cells (Haddad, I. Y., et al. 1996). 
The experiments described here clearly indicate that SIN-1 can readily pass 
through cell membranes. In L-929 cells the uptake of SIN-1 was directly measured 
and the intracellular production of RNOS was corroborated by DAF-2 nitrosation 
and NAD(P)H oxidation, respectively. The exclusion of propidium iodide and the 
fact that neither DAF-2T nor NAD(P)H did leak out of the cells during the duration 
of the experiments indicated that the plasma membrane remained intact. The 
finding that SIN-1 may readily pass the plasma membrane of cells is in line with 
observations of Meinertz et al. (Meinertz, T., et al. 1985), who detected SIN-1 in 
human plasma after molsidomine administration. Since SIN-1 is intracellularly 
formed from the prodrug molsidomine in the liver, SIN-1 obviously penetrates the 
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plasma membrane of hepatocytes with an efficiency similar to the one observed 
here for L-929 cells. 
The intracellular formation of freely diffusing NO from SIN-1 ([NO]SIN-1) should 
decisively depend on the local superoxide dismutase activity due to competition 
between NO and SOD for O2.–. Because natural SOD activities strongly vary with 
the type of the cells (ca. 4-400 units/ml=0,025-2,5 µM) (Minami, M. and 
Yoshikawa, H. 1979, Oyanagui, Y. 1984), the nature and yields of the reactive 
nitrosating intermediates produced from intracellularly decaying SIN-1 likewise 
should be strongly dependent on cell type. The chemical situation in the 
intracellular milieu will be further complicated for cells actively producing NO via 
the NOS arginine pathway ([NO]NOS). In such a case, an increased amount of O2.– 
will be trapped by endogenously produced NO rather than by SOD. Hence, SOD 
will be less effective in inhibiting the formation of peroxynitrite from intracellular 
decaying SIN-1. From the reported rate constants of O2.– with both NO and SOD 
(Kissner, R. and Koppenol, W. H. 2002, Ross, A. B., et al. 1998), one can estimate 
that the intracellular formation of peroxynitrite from SIN-1 is preferred at 
concentration ratios [NO]total / [SOD] ≥ 0.1-0.5 with [NO]total = [NO]NOS + [NO]SIN-1. 
The situation may be changed when the cell type (for instance bovine aortic 
endothelial cells (BAECs)) is highly effective in releasing NO under basal 
conditions, because intracellularly decaying SIN-1 is then expected to be (more or 
less) quantitatively converted into peroxynitrite (Christoph, S., et al. 2004). 
However, the decay of SIN-1 is strongly hampered in the intracellular milieu of 
BAECs so that the SIN-1-induced oxidation of cellular NAD(P)H could only be 
observed during the first initial 10 min of incubation (Christoph, S., et al. 2004). 
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The fact that the intracellular concentration of SIN-1 is four-fold higher in BAECs 
(Christoph, S., et al. 2004) than in L-929 cells may conclusively explain this 
decreased decay because the intracellular oxygen concentration necessary for 
supporting the decay of SIN-1 should be four-times faster consumed in BAECs 
than in L-929 cells.  
As a consequence of both the endogenous nitric oxide and the hampered decay of 
SIN-1 in BAECs, no exogenous NO is released from SIN-1. Since intracellular SIN-
1 may generate both nitric oxide and RNOS, intracellular NAD(P)H may be 
diametrically affected. Nitric oxide is known to inhibit the respiratory chain and to 
increase the cellular NAD(P)H level (Horie, Y., et al. 1997, Radi, R., et al. 2002) 
(Fig. 14), whereas peroxynitrite and other RNOS should be highly effective in 
oxidizing NAD(P)H either directly (Goldstein, S. and Czapski, G. 2000, Kirsch, M. 
and de Groot, H. 1999, Kirsch, M. and de Groot, H. 2001, Kirsch, M. and de Groot, 
H. 2000, Kirsch, M. and de Groot, H. 2002, Kuhn, D. M. and Geddes, T. J. 2002, 
Schmidt, H. H. H. W., et al. 1996) or indirectly by an enhanced oxidation of 
glutathione (Buckley, B. J. and Whorton, A. R. 2000, Everett, S. A., et al. 1996, 
Heales, S. J. R. and Bolanos, J. P. 2002, Kirsch, M. and de Groot, H. 2001, Kirsch, 
M., et al. 2002, Mayer, B., et al. 1998, Radi, R., et al. 1991, Tu, B., et al. 1995) thus 
resulting in a decrease of the NADPH level due to the enzymatic action of 
glutathione reductase (Kirsch, M. and de Groot, H. 2001). In addition, some 
authors propose a capability of peroxynitrite to irreversibly inhibit the respiratory 
chain (see for example (Radi, R., et al. 1994) and references herein). However, as 
in cellular systems peroxynitrite mediates its harmful effects most likely via the 
radicals NO2. and CO3.– (Bonini, M. G., et al. 1999, Lehnig, M. 1999), and because 
NAD(P)H readily reacts with these radicals (Goldstein, S. and Czapski, G. 2000, 
  
50
Kirsch, M. and de Groot, H. 1999, Kirsch, M. and de Groot, H. 2001), a 
peroxynitrite-mediated irreversible inhibition of the respiratory chain must also be 
accompanied by an initial decrease of mitochondrial NAD(P)H. We can safely 
exclude this possibility for L-929 cells, because SIN-1 increased the mitochondrial 
level of NAD(P)H by approximately ~12% (Fig. 15B). This possibility depends on 
the cell type (Christoph, S., et al. 2004), as SIN-1 initially decreased the 
mitochondrial NAD(P)H level in BAECs by about 20% as expected from action of 
peroxynitrite. Thome et al. (Thome, U., et al. 2003) claimed that peroxynitrite can 
directly attack SIN-1, thereby generating poorly characterized “bioactive” 
compounds. However, the experiments of Thome et al. are likely to be flawed by 
the presence of the buffer HEPES, which by attack of peroxynitrite or radicals 
derived from it will cause random formation of O2.–, H2O2, and a yet 
uncharacterized “nitric oxide donating compound” (Kirsch, M., et al. 1998, 
Lomonosova, E., et al. 1998, Schmidt, K., et al. 1998). Finally, an effective reaction 
between peroxynitrite and SIN-1 appears highly unlikely because SIN-1 (50-1000 
µM) is unable to inhibit the peroxynitrite (250 µM)-mediated oxidation of NADH 
(200 µM) at pH 6.5 (unpublished results). 
Recently, Garcia-Nogales et al. (Garcia-Nogales, P., et al. 2003) studied the 
effects of SIN-1 as a putative peroxynitrite generator on both astrocytes and 
neurons and observed that peroxynitrite increases the total NAD(P)H concentration 
in these cells by about 80%. This increase in the total cellular NAD(P)H 
concentration was taken as an argument to question the relevance of the 
observation that peroxynitrite is highly effective in oxidizing NAD(P)H in vitro 
(Kirsch, M. and de Groot, H. 1999, Kirsch, M. and de Groot, H. 2001, Kirsch, M. 
and de Groot, H. 2000). However, singlet oxygen can directly oxidize mitochondrial 
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NAD(P)H (Petrat, F., et al. 2003) and the questions arises why the even more 
powerful CO3.– radical (k(NADH + CO3.–) = 1.4 x 109 M -1s-1, (Goldstein, S. and 
Czapski, G. 2000) should not act in a similar manner. Experiments performed with 
BAECs (Christoph, S., et al. 2004) suggest that an increase in NAD(P)H is 
obviously a secondary metabolic response of these cells to the rapid NAD(P)H 
consumption induced by in situ generated peroxynitrite from SIN-1. Remarkably, 
such an enhanced NAD(P)H production seems to be cell-type specific because 
upon addition of SIN-1 to L-929 cells the basal NAD(P)H level was increased in 
mitochondria but decreased in the cytosol and in the nuclei (Fig. 15B). The 
complexity of the influence of SIN-1 on cellular NAD(P)H homeostasis is further 
underlined by the observation that in L-929 the cytosolic level of NAD(P)H 
increases at prolonged incubation periods, apparently at the expense of 
mitochondrial NAD(P)H. 
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6 CONCLUSIONS 
SIN-1 is highly effective in penetrating plasma membranes of cells but the uptake 
of SIN-1 and the decay rate of it in the intracellular milieu depends on the cell type. 
The formation of peroxynitrite from intracellularly decaying SIN-1 should be 
suppressed by SOD and favored by endogenously produced nitric oxide. Hence, 
the use of SIN-1 for cell culture studies a priori will affect the cells in an 
unpredictable manner both by extracellular generation of peroxynitrite as well as by 
modulation the relative levels of intracellularly produced nitric oxide and RNOS, 
e.g. peroxynitrite. The cellular NAD(P)H level might be used to indicate whether 
nitric oxide or RNOS are predominantly affecting the physiological processes in the 
various cell compartments under a certain experimental condition. It is therefore 
highly problematic to employ SIN-1 as a reliable source for peroxynitrite in cell 
culture experiments. 
  
53
7 SUMMARY 
The drug molsidomine is metabolized by hepatic esterases to SIN-1 that further 
reacts with molecular oxygen to yield nitric oxide and superoxide. Both radicals can 
recombine to give the harmful entity peroxynitrite. Consequently, SIN-1 is 
frequently used in cell culture studies as (an extracellularly operating) peroxynitrite 
generator. However, little is known about the nature of the reactive species 
produced intracellulary from SIN-1. In the present study I demonstrated that SIN-1 
can easily penetrate cell membranes as exemplified with L-929 mouse fibroblasts. 
Intracellularly decaying SIN-1 partly generates nitric oxide as monitored by two 
independent methods, i.e. the fluorescent nitric oxide scavenger FNOCT-1 and the 
nitric oxide electrode. Moreover, reactive nitrogen-oxide species (e.g. peroxynitrite, 
nitrogen dioxide, dinitrogen trioxide) were intracellularly formed as detected with 
the scavenger DAF-2. Laser scanning microscopy revealed that in L-929 cells SIN-
1-derived species initially oxidized the major fraction of the NAD(P)H within the 
cytosol and the nuclei, whereas the mitochondrial level of NAD(P)H was somewhat 
increased. This opposite behavior is conclusively explained by the capabilities of 
SIN-1 to simultaneously generate reactive nitrogen-oxide species (like peroxynitrite 
and dinitrogen trioxide) and freely diffusing nitric oxide in the intracellular milieu. 
These observations may lead to the conclusion that SIN-1 penetrated in vivo its 
target cells in order to stimulate the release of freely diffusing NO. Nitric oxide as 
well as RNOS decisively affect cellular metabolism, a fact that should be examined 
in cell culture systems by detecting the NAD(P)H level. In any case care should be 
taken in experimental systems to apply SIN-1 as an exclusively peroxynitrite-
generating compound. 
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9 APPENDIX: Abbreviations 
ACE angiotensine converting enzyme 
BAEC Bovine aortic endothelial cells 
cGMP cyclic guanosine monophosphate 
CO3•— trioxocarbonate(1-) 
DAF-2 DA  4.5- diaminofluorescein diacetate 
FNOCT-1 Fluorescent Nitric Oxide Cheletropic 
Trap-1 
MEM minimum essential medium 
MOPS 3-morpholino-propane-sulfone acid 
NO nitric oxide 
NOS I-III nitric oxide synthase I-III 
ONOO— oxoperoxonitrate(1-) 
ONOO—/ONOOH Peroxynitrite 
ONOOH hydrogen oxoperoxonitrate(1-) 
PBS phosphate buffered saline 
RAS  renin angiotensin system 
sGC  soluble guanylyl cyclase 
SIN-1 3-morpholino-sydnonimine 
SIN-1C N-morpholinoiminosydnonimine 
SOD superoxide dismutase 
spermineNONOate (Z)-1-⎨N-[3-aminopropyl]-N-[4-(3-
aminopropylammonio)butyl]-amino⎬-
diazen-1-ium-1,2diolate 
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